Blocking the CCL2/CCR4 axis in Tregs evokes an anti-tumor immune response in a model of head and neck squamous cell carcinoma (202) while blocking of CCL2/CCR4 axis on CTLs could be detrimental as argued in the study (203). This evidence concerns the gene CCL2 and head and neck squamous cell carcinoma.